申请人:CELTAXSYS, INC.
公开号:US20190161437A1
公开(公告)日:2019-05-30
This present disclosure is directed to compounds of formula (I):
where R
1a
, R
1b
, R
1c
, R
1d
, R
1c
, R
3
, R
4a
, R
4c
, R
4d
, R
6
, R
7
, and R
8
are described herein as , single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A
4
hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions including the compounds described herein and methods of preparing the compounds described herein are also provided.